Literature DB >> 9142182

Surgical Treatment of sacrococcygeal chordoma.

T Ozaki1, A Hillmann, W Winkelmann.   

Abstract

BACKGROUND: Sacrococcygeal chordomas are difficult to manage.
METHODS: The treatment results of 12 patients with sacral chordomas were analyzed. Four patients had local relapse before they were referred to our hospital: three patients previously underwent two surgeries, and one patient one surgery and irradiation (60 Gy). In this institute, 10 patients underwent surgery alone, and one had surgery plus postoperative irradiation. One patient underwent radiotherapy alone due to an inoperable lesion that reached to the L5 spine. For seven surviving patients, the average follow-up period was 50 months.
RESULTS: One of four patients with a marginal margin and one of two patients with a contaminated margin developed local relapse. Of five patients with intralesional margins, four patients developed local relapse and two had metastasis to the spine and lungs 36 and 15 months after surgery, respectively. One patient with irradiation alone had metastasis to the lungs 15 months after initiation of treatment. Three patients died due to progression of the disease, one of a heart problem and one of apoplexy. One of 10 patients with implantation of gentamycin beads after removal of tumor, developed infection.
CONCLUSIONS: For local control of sacral chordomas, an adequate surgical margin is important. Gentamycin beads may be effective to control postoperative infection of the dead space.

Entities:  

Mesh:

Year:  1997        PMID: 9142182     DOI: 10.1002/(sici)1096-9098(199704)64:4<274::aid-jso5>3.0.co;2-6

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  16 in total

Review 1.  Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review.

Authors:  Carmine Zoccali; Jesse Skoch; Apar S Patel; Christina M Walter; Philip Maykowski; Ali A Baaj
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

2.  Experience with wound complications after surgery for sacral tumors.

Authors:  Dasen Li; Wei Guo; Huayi Qu; Rongli Yang; Xiaodong Tang; Taiqiang Yan; Shun Tang; Yi Yang; Tao Ji; Sen Dong
Journal:  Eur Spine J       Date:  2013-04-16       Impact factor: 3.134

3.  Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.

Authors:  Ziya L Gokaslan; Patricia L Zadnik; Daniel M Sciubba; Niccole Germscheid; C Rory Goodwin; Jean-Paul Wolinsky; Chetan Bettegowda; Mari L Groves; Alessandro Luzzati; Laurence D Rhines; Charles G Fisher; Peter Pal Varga; Mark B Dekutoski; Michelle J Clarke; Michael G Fehlings; Nasir A Quraishi; Dean Chou; Jeremy J Reynolds; Richard P Williams; Norio Kawahara; Stefano Boriani
Journal:  J Neurosurg Spine       Date:  2015-12-18

4.  Carbon ion radiotherapy for sacral chordoma.

Authors:  R Imai; T Kamada; S Sugahara; H Tsuji; H Tsujii
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

5.  [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.

Authors:  Matthew D Cheney; Yen-Lin Chen; Ruth Lim; Barbara K Winrich; Anca L Grosu; Alexei V Trofimov; Nicolas Depauw; Helen A Shih; Joseph H Schwab; Francis J Hornicek; Thomas F DeLaney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

6.  Hand metastasis from a sacral chordoma.

Authors:  M Emori; M Kaya; S Sugita; T Soma; M Sasaki; T Yamashita
Journal:  Ann R Coll Surg Engl       Date:  2014-11       Impact factor: 1.891

7.  Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.

Authors:  M Mima; Y Demizu; D Jin; N Hashimoto; M Takagi; K Terashima; O Fujii; Y Niwa; T Akagi; T Daimon; Y Hishikawa; M Abe; M Murakami; R Sasaki; N Fuwa
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

8.  Adjuvant Stereotactic Radiosurgery and Radiation Therapy for the Treatment of Intracranial Chordomas.

Authors:  Winward Choy; Sergei Terterov; Nolan Ung; Tania Kaprealian; Andy Trang; Antonio DeSalles; Lawrance K Chung; Neil Martin; Michael Selch; Marvin Bergsneider; William Yong; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2015-08-03

9.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

10.  Chordoma and chondrosarcoma gene profile: implications for immunotherapy.

Authors:  Joseph H Schwab; Patrick J Boland; Narasimhan P Agaram; Nicholas D Socci; Tianhua Guo; Gary C O'Toole; Xinhui Wang; Elena Ostroumov; Christopher J Hunter; Joel A Block; Stephen Doty; Soldano Ferrone; John H Healey; Cristina R Antonescu
Journal:  Cancer Immunol Immunother       Date:  2008-07-19       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.